FBCM
AGN

Fort Baker Capital Management’s Allergan plc AGN Stock Holding History

Fort Baker Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,586
Closed -$2.05M – 40
2020
Q1 		$2.05M Buy
+11,586
New +$2.18M 1.36% 21
2019
Q4 		– Sell
-87,330
Closed -$14.7M – 27
2019
Q3 		$14.7M Buy
+87,330
New +$14.2M 13.56% 3

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Fort Baker Capital Management's AGN Position: Q2 2020 in Review

Fort Baker Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 11,586 shares — an estimated $2.05M sold.

Fort Baker Capital Management first reported a position in AGN in Q3 2019 and held it in 2 quarters. The position peaked at $14.7M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Fort Baker Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Fort Baker Capital Management sold 11,586 Allergan plc shares in Q2 2020, an estimated $2.05M.
  • Fort Baker Capital Management first reported a position in Allergan plc in Q3 2019 and held it in 2 quarters.
  • Fort Baker Capital Management's Allergan plc position peaked at $14.7M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Fort Baker Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.